Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026

Impact · against what's priced in

The announcement of a financial results date and business update for Protalix BioTherapeutics is a routine scheduling event. While the upcoming call may provide updates on cash runway and regulatory progress for PRX-115 and PRX-119, the announcement itself does not contain material news.

PFE+0.00

No priced-in read yet